RAB11A and breast cancer: Indeed, PI4KB was found to drive the development of all breast cancer subtypes and was shown to co-operate with the small Rab GTPase, Rab11a, to promote breast cancer oncogenesis via a novel Akt activation pathway (Morrow et al., 2014[57]; Silva et al., 2015[75]).